Education
About Us
Working with TipRanks
Follow Us
bluebird bio (BLUE)
NASDAQ:BLUE
Total Valuation
Bluebird Bio has a market cap or net worth of $38.18M. The enterprise value is $390.74M.
Market Cap$38.18M
Enterprise Value$390.74M
Share Statistics
Bluebird Bio has 9,790,070 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding9,790,070
Owned by Insiders9.50%
Owned by Institutions<0.01%
Financial Efficiency
Bluebird Bio’s return on equity (ROE) is 7.63 and return on invested capital (ROIC) is -106.97%.
Return on Equity (ROE)7.63
Return on Assets (ROA)-0.52
Return on Invested Capital (ROIC)-106.97%
Return on Capital Employed (ROCE)-1.95
Revenue Per Employee337.93K
Profits Per Employee-970.63K
Employee Count248
Asset Turnover0.18
Inventory Turnover1.37
Valuation Ratios
The current PE Ratio of Bluebird Bio is -0.34. Bluebird Bio’s PEG ratio is >-0.01.
PE Ratio-0.34
PS Ratio0.71
PB Ratio-2.56
Price to Fair Value-2.56
Price to FCF-0.31
Price to Operating Cash Flow-0.31
PEG Ratio>-0.01
Income Statement
In the last 12 months, Bluebird Bio had revenue of 83.81M and earned -240.72M in profits. Earnings per share was -24.84.
Revenue83.81M
Gross Profit-5.57M
Operating Income-270.46M
Pretax Income-240.65M
Net Income-240.72M
EBITDA-270.46M
Earnings Per Share (EPS)-24.84
Cash Flow
In the last 12 months, operating cash flow was -223.69M and capital expenditures -7.33M, giving a free cash flow of -231.02M billion.
Operating Cash Flow-223.69M
Free Cash Flow-231.02M
Free Cash Flow per Share-23.60
Dividends & Yields
Bluebird Bio pays an annual dividend of $177.66, resulting in a dividend yield of ―
Dividend Per Share$177.66
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.62
52-Week Price Change-77.64%
50-Day Moving Average4.63
200-Day Moving Average9.99
Relative Strength Index (RSI)46.80
Average Volume (3m)429.10K
Important Dates
Bluebird Bio upcoming earnings date is May 7, 2025, TBA Not Confirmed.
Last Earnings DateFeb 25, 2025
Next Earnings DateMay 7, 2025
Ex-Dividend DateNov 05, 2021
Financial Position
Bluebird Bio as a current ratio of 0.48, with Debt / Equity ratio of -6367.13%
Current Ratio0.48
Quick Ratio0.28
Debt to Market Cap3.51
Net Debt to EBITDA-0.82
Interest Coverage Ratio11.98
Taxes
In the past 12 months, Bluebird Bio has paid -70.00K in taxes.
Income Tax-70.00K
Effective Tax Rate<0.01
Enterprise Valuation
Bluebird Bio EV to EBITDA ratio is -1.12, with an EV/FCF ratio of -1.15.
EV to Sales3.60
EV to EBITDA-1.12
EV to Free Cash Flow-1.15
EV to Operating Cash Flow-1.16
Balance Sheet
Bluebird Bio has $70.65M in cash and marketable securities with $0.00 in debt, giving a net cash position of $297.75M billion.
Cash & Marketable Securities$70.65M
Total Debt$0.00
Net Cash$297.75M
Net Cash Per Share$30.41
Tangible Book Value Per Share-$4.82
Margins
Gross margin is -43.49%, with operating margin of -322.72%, and net profit margin of -287.23%.
Gross Margin-43.49%
Operating Margin-322.72%
Pretax Margin-287.14%
Net Profit Margin-287.23%
EBITDA Margin-322.72%
EBIT Margin-314.08%
Analyst Forecast
The average price target for Bluebird Bio is $6.00, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target$6.00
Price Target Upside38.25% Upside
Analyst ConsensusHold
Analyst Count4
Revenue Growth Forecast184.12%
EPS Growth Forecast31.92%